Dr. Souayah PUBLICATIONS

The following Dr Souayah publications are selected from more than 400 manuscripts and abstracts :

Neuromuscular Second Opinions

Bril V, Berkowicz T, Szczudlik A, Nicolle MW, … Souayah N. (2025). Efficacy and safety of maintenance IVIG in generalized myasthenia gravis. Muscle & Nerve, 71(1), 43–54.

Bril V, Hadden R, Brannagan T, … Souayah N. (2023). Subcutaneous immunoglobulin in CIDP: ADVANCE-CIDP 1 trial. J Peripher Nerv Syst, 28(2), 123–136.

Layton JB, Ritchey ME, Huang Z, … Souayah N. (2023). IVIG initiation in CIDP: US cohort study. Neurol Ther, 12, 1171–1186.

Souayah N. et al. (2024). Novel markers for demyelination in diabetic neuropathy. Heliyon, 10(9), e30419.

Souayah N. et al. (2023). Electrodiagnostic profile of conduction slowing in ALS. Heliyon, 9(8), e18400.

Complex Neurological Disorders

Chong ZZ, Souayah N.(2025). Targeting Gene C9orf72 in ALS. Int J Mol Sci, 26(9).

Chong ZZ, Souayah N. (2025). Pathogenic TDP-43 in ALS. Drug Discov Today, 30(5), 104351.

Chong ZZ, Menkes DL, Souayah N. (2023). C9orf72 expansions and ALS pathogenesis. Rev Neurosci, 34(3), 251–265.

Chong ZZ, Souayah N. (2025). Oxidative stress in chronic neurodegeneration. Antioxidants (Basel), 14(6).

Neuro-Wellness, Diabetes & Longevity Neurology

Chong ZZ, Souayah N. (2025). Neuroinflammation in diabetic neuropathy. Rev Neurosci, 36(2).

Chong ZZ, Souayah N. (2025). Biomarkers in diabetic peripheral neuropathy. Biomedicines, in press.

Sharma R, Chong ZZ, Menkes DL, Souayah N. (2024). Oxidative stress in diabetic neuropathy. Clin Trials Anal Geek Chron, 1(1):1–13.

Souayah N., Chen L, Maybodi L. (2012). Urine phospholipase as a marker for neuroinflammation in diabetic neuropathy. Muscle & Nerve, 44(6), 843–850.

Expert Services: Vaccine & Post-Infectious Neurology

Jaffry M, Aftab O, Mostafa F, … Souayah N. (2023). Optic neuritis after COVID-19 vaccination: VAERS analysis. J Neuroophthalmol, 43(4), 512–520.

Jaffry M, Mostafa F, Mandava K, … Souayah N. (2022). No significant increase in GBS after COVID-19 vaccination. Vaccine, 40(40), 5791–5797.

Thepmankorn P, Gomez F, El-Ghanem M, … Souayah N. (2021). Influenza vaccination and GBS: VAERS/VSD analysis. Healthcare Res J, 2(1), 45–52.

Souayah N. et al. (2012). Guillain-Barré after H1N1 vaccination: VAERS. Neuroepidemiology, 38, 227–232.

Souayah N. et al. (2009). Small fiber neuropathy after rabies, varicella, or Lyme vaccination. Vaccine, 27, 7322–7325.

Health Economics, AI & Outcomes

Zhdanava M, Pesa J, Boonmak P, … Souayah N.(2024). Predictors of high cost in CIDP: Machine learning approach. Appl Health Econ Health Policy.

Zhdanava M, Pesa J, Boonmak P, … Souayah N. (2024). Economic burden of myasthenia gravis in the US. Curr Med Res Opin, 40(7), 1145–1153.